The Sumaira Foundation is a 501(c)(3) organization dedicated to generating global awareness of NMOSD* and MOGAD*, building communities of support for patients and their caregivers, supporting research and patient advocacy
Neuromyelitis optica spectrum disorder (NMOSD) is a rare neuroimmune condition in which the immune system attacks cells in the central nervous system (CNS), mistaking them for foreign invaders. Common symptoms include vision loss, color vision deficiency, paralysis, paraparesis, weakness, numbness, spasticity, vomiting, hiccups, and bladder/bowel dysfunction.
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare neuroimmune condition that targets the MOG protein which is located on the surface of myelin sheaths in the central nervous system. Common symptoms include vision loss, color vision deficiency, paralysis, paraparesis, weakness, numbness, spasticity, vomiting, hiccups, seizures, and bladder/bowel dysfunction.
Raise awareness.
Build community.
Support research.
Advocate.
